The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.
“TRIBUTE TO DR. CANDACE KENDLE” mentioning the U.S. Dept of State was published in the Senate section on pages S2611 on April 27, 2017.
The State Department is responsibly for international relations with a budget of more than $50 billion. Tenure at the State Dept. is increasingly tenuous and it's seen as an extension of the President's will, ambitions and flaws.
The publication is reproduced in full below:
TRIBUTE TO DR. CANDACE KENDLE
Mr. PORTMAN. Mr. President, today I wish to recognize the contributions of Dr. Candace Kendle, recipient of the 2017 Lifetime Achievement Award from the Association for Corporate Growth, Cincinnati.
As the visionary cofounder of one of the largest international providers of drug development services to the biopharmaceutical industry, Dr. Candace Kendle is being honored for her achievements in founding and growing Kendle International, Inc., from a small, private startup in 1981, to a global clinical research organization traded on NASDAQ, KNDL, and acquired by INC Research in 2011.
Under Dr. Kendle's leadership, Kendle International delivered a wide range of clinical development and clinical trial services to biopharmaceutical companies around the world, including the development of Celebrex.
Prior to founding Kendle International, Inc., Kendle held senior faculty positions at several leading academic institutions, including the University of North Carolina, Chapel Hill, Schools of Pharmacy and Medicine; the University of Pennsylvania, School of Medicine; Philadelphia College of Pharmacy and Science; and the University of Cincinnati College of Pharmacy.
A first-generation college student, Dr. Candace Kendle earned a bachelor of science and doctorate in pharmacy from the University of Cincinnati, College of Pharmacy, and was awarded an honorary Ph.D. in science from the University of Cincinnati in 2010.
Dr. Candace Kendle is recognized worldwide as a leader in the CRO industry and is a founding member and past chairperson of the Association of Clinical Research Organizations. She has served as a mentor for the Fortune--U.S. State Department Global Women Leaders Mentoring Partnership and as a member of the Committee of 200, where she served on the board of directors for its foundation. She has also served on biotechnology task forces for the U.S. Department of Commerce, as well as for two Ohio Governors.
Dr. Kendle serves on the boards of directors for USP, Emerson, and the H.J. Heinz Company. She is cofounder of Next Chapter Press and ReadAloud.org, an organization to encourage children and adults to read aloud to encourage lifelong learning. She is also a former trustee for the University of Cincinnati, the National Underground Railroad Freedom Center, and numerous other nonprofit organizations.
____________________
